Baldoni John 4
4 · MiNK Therapeutics, Inc. · Filed Sep 6, 2023
Insider Transaction Report
Form 4
Baldoni John
Director
Transactions
- Award
Common stock
2023-09-01$1.46/sh+9,846$14,375→ 41,193 total
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
- [F2]In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 7,987 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 31,347 instead of 31,528 as erroneously reported.